52
CAD Therapeutics raises $10M in first Regulation D offering
Company raise · Raising · NEW YORK, NY · Form D filed 2026-10-02
CAD Therapeutics, a Delaware biotech corporation based in New York, is raising $10M under Regulation D exemption 6(b). The company has sold $4M to 2 investors so far and has $6M remaining in the offering.
Note: New issuer on EDGAR; first raise on record. Minimum investment listed as $0, which may indicate flexible terms or data entry artifact.
$10M+ raiseFirst raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| CHRISTOPHER TEAS | PRESIDENT |
| SORINA BURI | Director |
Signed by CHRISTOPHER TEAS, PRESIDENT.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.